TIBERGYN

TIBERGYN has been active since 1985 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €763,636 and a net result of €133,500. Equity remains stable across the filed financial years (±0.9% per year). Its solvency ranks better than 94% of 16,839 sector peers (NACE 56, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).